Several GLP-1 medications were first approved for type 2 diabetes, but some patients were later prescribed off-label versions of these drugs for weight loss before separate obesity-specific formulations became available
2021 Jul 13;36(2):109374
Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4
It alters hunger hormones, metabolism, diabetes progression, sleep apnea, blood pressure, [and] mobility. Terushkin added that laparoscopic surgery, a type of procedure where a thin tube with a camera and a light on it is inserted through an incision in the abdomen, is not what many people expect
Over 72 weeks patients without diabetes lost 15%, 19%, and 21% of body weight on the 5, 10, and 15 mg weekly SQ injections, respectively
Let's talk off-label use Some doctors prescribe medications approved for certain conditions to treat others, a practice known as off-label prescribing